natalizumab - CISMeF

Preferred Label : natalizumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details

Origin ID

M0443607;

UMLS CUI

C1172734;

Currated CISMeF NLP mapping
- Natalizumab [LOINC component]
- Natalizumab [SMS substance]
- Natalizumab [ICD-11 Extension code]
- Natalizumab [Anticorps monoclonal]
- Natalizumab [NCIt concept]
- Natalizumab (substance) [SNOMED CT concept]
- natalizumab [International Nonproprietary Name]
MeSH narrower concept(s)
- antegren [MeSH concept]
- tysabri [MeSH concept]
Related record
- Natalizumab [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Natalizumab [LOINC component]
- Natalizumab [NCIt concept]
- Natalizumab (substance) [SNOMED CT concept]
- Product containing natalizumab (medicinal product) [SNOMED CT concept]
- natalizumab [ATC Code]
- natalizumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- natalizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients